Autologous blood pleurodesis: A good choice in patients with persistent air leak

Ufuk Cobanoglu, Mehmet Melek, Yesim Edirne, Ufuk Cobanoglu, Mehmet Melek, Yesim Edirne

Abstract

Aim: The study compares the efficiency, side effects and complications of autologous blood pleurodesis with talcum powder and tetracycline.

Materials and methods: This prospective study evaluated 50 patients with persistent air leak resulting from primary and secssondary spontaneous pneumothorax between February 2004 and March 2009. The patients inclussded 32 (64.0%) males and 18 (36.0%) females with a median age of 39 years (range 14-69 years). All cases had persistent air leak of more than seven days. Pleurodesis was performed using autologous blood in 20 (40.0%) patients, talc powder in 19 (38.0%) patients and tetracycline in 11 (22.0%) patients through a chest tube. Air leak cessation times after pleurodesis, side effects and pulmonary function tests (PFT) in the first and third months were measured.

Results: Recurrent primary spontaneous pneumothorax was the cause of persistent air leak in all cases. Air leaks were expiratory only in 54.0% of cases. We obtained a success rate of 75.0% using autologous blood, 84.2% using talc powder and 63.6% using tetracycline. Mean air leak termination interval was significantly (P < 0.001) shorter in patients treated with autologous blood in comparison to talc powder and tetracycline. We observed a significant (P < 0.05) decline in PFT in patients treated with talc powder compared with tetracycline and autologous blood. Vital capacity, FVC and FEV₁were significantly lower in patients treated with tetracycline compared with autologous blood.

Conclusion: This study shows that autologous blood pleurodesis compared to talc powder and tetracycline is related with shorter leak cessation time and less pulmonary function decline in patients with persistent air leak. We think further randomized clinical trials of pleurodesis as treatment could increase its use in thorax surgery by demonstrating the safety and the efficacy of this procedure.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Flow-chart of patients

References

    1. Cerfolio RJ, Tummala RP, Holman WL, Zorn GL, Kirklin JK, McGiffin DC, et al. A prospective algorithm for the management of air leaks after pulmonary resection. Ann Thorac Surg. 1998;66:1726–31.
    1. Rice TW, Kirby TJ. Prolonged air leak. Chest Surg Clin North Am. 1992;2:803–11.
    1. Rivas de Andres JJ, Blanco S, de la Torre M. Postsurgical pleurodesis with autologous blood in patients with persistent air leak. Ann Thorac Surg. 2000;70:270–2.
    1. Thistlethwaite PA, Luketich JD, Ferson PF, Jamieson SW. Ablation of persistent air leaks after thoracic procedures with fibrin sealant. Ann Thorac Surg. 1999;67:575–7.
    1. Bouros D, Froudarakis M, Siafakas NM. Pleurodesis. Chest. 2000;118:577–8.
    1. Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology. 2001;6:181–5.
    1. Rehse DH, Ayer RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg. 1999;177:437–40.
    1. Dumire R, Crabbe MM, Mappin FG, Fontenelle LJ. Autologous ‘blood patch’ pleurodesis for persistent pulmonary air leak. Chest. 1992;101:64–6.
    1. Shackloth M, Poullis M, Page R. Autologous blood pleurodesis for treating persistent air leak after lung resection. Ann Thorac Surg. 2001;71:1402–3.
    1. Almassi GH, Haasler GB. Chemical pleurodesis in the presence of persistent air leak. Thorac Surg. 1989;47:786–7.
    1. Lang-Lazdunski L, Chapuis O, Bonnet PM, Pons F, Jancovici R. Videothoracoscopic bleb excision and pleural abrasion for the treatment of primary spontaneous pneumothorax: Long-term results. Ann Thorac Surg. 2003;75:960–5.
    1. Macoviak JA, Stephenson LW, Ochs R, Edmunds LH. Tetracydine pleurodesis during active pulmonary-pleural air leak for prevention ofrecurrent pneumothorax. Chest. 1982;81:78–81.
    1. Bouchama A, Chastre J, Gaudichet A, Soler P, Gibert C. Acute pneumothorax with bilateral pleural effusion after talc pleurodesis. Chest. 1984;86:798–9.
    1. Lange P, Mortenson J, Groth J. Lung function 22-35 years after treatment of idiopathic spontaneous pneumothorax with talc poudrage of simple drainage. Thorax. 1988;43:561–99.
    1. Robinson CL. Autologous blood for pleurodesis in recurrent and chronic spontaneous pneumothorax. Can J Surg. 1987;30:428–9.
    1. Cagirici U, Sahin B, Cakan A, Kabayas H, Budunelli T. Autologous blood patch pleurodesis in spontaneous pneumothorax with persistent air leak. Scand Cardiovasc J. 1998;32:75–8.
    1. Lang-Lazdunski L, Coonar AS. A prospective study of autologous ‘blood patch’ pleurodesis for persistent air leak after pulmonary resection. Eur J Cardiothorac Surg. 2004;26:897–900.
    1. Mitchem RE, Herndon BL, Fiorella RM, Molteni A, Battie CN, Reisz GR. Pleurodesis by autologous blood, doxycycline, and talc in a rabbit model. Ann Thorac Surg. 1999;67:917–21.
    1. De Vries WC, Wolfe WG. The management of spontaneous pneumothorax and bullous emphysema. Surg Clin North Am. 1980;60:851–66.
    1. Granke K, Fischer CR, Gago O, Morris JD, Prager RL. The efficacy and timing of operative intervention for spontaneous pneumothorax. Ann Thorax Surg. 1986;42:540–2.
    1. Tanaka F, Itoh M, Esaki H, Isobe J, Ueno Y, Inoue R. Secondary Spontaneous Pneumothorax. Ann Thorac Surg. 1993;55:372–6.
    1. Jantzing HM, Derom A, Derom E, Eeckhout C, Derom F, Rossel MT. Intrapleural quinacrine instillation for recurrent pneumothorax or persistent air leak. Ann Thorac Surg. 1993;55:368–71.
    1. Antunes G, Neville E. Management of malignant pleural effusions. Thorax. 2000;55:981–3.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj